Literature DB >> 26299953

Protease Omi cleaving Hax-1 protein contributes to OGD/R-induced mitochondrial damage in neuroblastoma N2a cells and cerebral injury in MCAO mice.

Jia-yuan Wu1, Mei Li1, Li-juan Cao1, Mei-ling Sun1, Dong Chen1, Hai-gang Ren1, Qin Xia1, Zhou-teng Tao1, Zheng-hong Qin1, Qing-song Hu1, Guang-hui Wang1.   

Abstract

AIM: In the penumbra after focal cerebral ischemia, an increase of protease Omi is linked to a decrease of Hs1-associated protein X-1 (Hax-1), a protein belonging to the Bcl-2 family. In this study we investigated the mechanisms underlying the regulation of Hax-1 by protease Omi in cerebral ischemia/reperfusion (I/R) injury.
METHODS: Mouse neuroblastoma N2a cells were subjected to oxygen-glucose deprivation and reoxygenation (OGD/R); cell viability was assessed with MTT assay. Mice underwent 2-h middle cerebral artery occlusion (MCAO) and reperfusion, and the infarct volume was determined with TTC staining. The expression of Omi and Hax-1 was detected using immunoblot and immunofluorescence assays. The mitochondrial membrane potential was measured using TMRM staining.
RESULTS: In the brains of MCAO mice, the protein level of Omi was significantly increased, while the protein level of Hax-1 was decreased. Similar changes were observed in OGD/R-treated N2a cells, but the mRNA level of Hax-1 was not changed. Furthermore, in OGD/R-treated N2a cells, knockdown of Omi significantly increased Hax-1 protein level. Immunofluorescence assay showed that Omi and Hax-1 were co-localized in mitochondria of N2a cells. OGD/R caused marked mitochondrial damage and apoptosis in N2a cells, while inhibition of Omi protease activity with UCF-101 (10 μmol/L) or overexpression of Hax-1 could restore the mitochondrial membrane potential and attenuate cell apoptosis. Moreover, pretreatment of MCAO mice with UCF-101 (7.15 mg/kg, ip) could restore Hax-1 expression, inhibit caspase activation, and significantly reduce the infarct volume.
CONCLUSION: Protease Omi impairs mitochondrial function by cleaving Hax-1, which induces apoptosis in OGD/R-treated N2a cells and causes I/R injury in MCAO mice.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26299953      PMCID: PMC4561969          DOI: 10.1038/aps.2015.50

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  40 in total

Review 1.  Mechanisms, challenges and opportunities in stroke.

Authors:  Eng H Lo; Turgay Dalkara; Michael A Moskowitz
Journal:  Nat Rev Neurosci       Date:  2003-05       Impact factor: 34.870

Review 2.  Apoptosis: future targets for neuroprotective strategies.

Authors:  Isidro Ferrer
Journal:  Cerebrovasc Dis       Date:  2006-05-02       Impact factor: 2.762

3.  Targeting thioredoxin-1 with siRNA exacerbates oxidative stress injury after cerebral ischemia/reperfusion in rats.

Authors:  L Li; K Zhu; Y Liu; X Wu; J Wu; Y Zhao; J Zhao
Journal:  Neuroscience       Date:  2014-11-08       Impact factor: 3.590

4.  Overexpression of HAX-1 protects cardiac myocytes from apoptosis through caspase-9 inhibition.

Authors:  Yuchi Han; Yee-Shiuan Chen; Zhilin Liu; Natalya Bodyak; Debra Rigor; Egbert Bisping; William T Pu; Peter M Kang
Journal:  Circ Res       Date:  2006-07-20       Impact factor: 17.367

5.  Function of BID -- a molecule of the bcl-2 family -- in ischemic cell death in the brain.

Authors:  Nikolaus Plesnila; Sandra Zinkel; Sepideh Amin-Hanjani; Jianhua Qiu; Stanley J Korsmeyer; Michael A Moskowitz
Journal:  Eur Surg Res       Date:  2002 Jan-Apr       Impact factor: 1.745

6.  BAX contributes to apoptotic-like death following neonatal hypoxia-ischemia: evidence for distinct apoptosis pathways.

Authors:  M E Gibson; B H Han; J Choi; C M Knudson; S J Korsmeyer; M Parsadanian; D M Holtzman
Journal:  Mol Med       Date:  2001-09       Impact factor: 6.354

7.  The protease Omi cleaves the mitogen-activated protein kinase kinase MEK1 to inhibit microglial activation.

Authors:  Qingsong Hu; Bin Li; Ranjie Xu; Dong Chen; Chenchen Mu; Erkang Fei; Guanghui Wang
Journal:  Sci Signal       Date:  2012-08-21       Impact factor: 8.192

8.  Mitochondrial protein quality control by the proteasome involves ubiquitination and the protease Omi.

Authors:  Susanne Radke; Harish Chander; Patrick Schäfer; Gregor Meiss; Rejko Krüger; Jörg B Schulz; Doris Germain
Journal:  J Biol Chem       Date:  2008-03-24       Impact factor: 5.157

9.  UCF-101, a novel Omi/HtrA2 inhibitor, protects against cerebral ischemia/reperfusion injury in rats.

Authors:  Danying Su; Zhiqiang Su; Jiaye Wang; Shanshan Yang; Jing Ma
Journal:  Anat Rec (Hoboken)       Date:  2009-06       Impact factor: 2.064

10.  Hax-1 is rapidly degraded by the proteasome dependent on its PEST sequence.

Authors:  Bin Li; Qingsong Hu; Ranjie Xu; Haigang Ren; Erkang Fei; Dong Chen; Guanghui Wang
Journal:  BMC Cell Biol       Date:  2012-07-24       Impact factor: 4.241

View more
  13 in total

1.  Vitamin K2 suppresses rotenone-induced microglial activation in vitro.

Authors:  Yan-Xia Yu; Yi-Pei Li; Feng Gao; Qing-Song Hu; Yan Zhang; Dong Chen; Guang-Hui Wang
Journal:  Acta Pharmacol Sin       Date:  2016-08-08       Impact factor: 6.150

2.  Humanin analogue, S14G-humanin, has neuroprotective effects against oxygen glucose deprivation/reoxygenation by reactivating Jak2/Stat3 signaling through the PI3K/AKT pathway.

Authors:  Guang-Sheng Gao; Yun Li; Heng Zhai; Jing-Wen Bi; Fu-Sen Zhang; Xiao-Ying Zhang; Shao-Hua Fan
Journal:  Exp Ther Med       Date:  2017-08-16       Impact factor: 2.447

3.  The protective effects of lncRNA ZFAS1/miR-421-3p/MEF2C axis on cerebral ischemia-reperfusion injury.

Authors:  Jiangqi Xu; Xiaohong Huang; Shixiang Liu; Dongdong Chen; Yufang Xie; Zhenwu Zhao
Journal:  Cell Cycle       Date:  2022-07-26       Impact factor: 5.173

4.  BMSC-Derived Exosomal Egr2 Ameliorates Ischemic Stroke by Directly Upregulating SIRT6 to Suppress Notch Signaling.

Authors:  Rongjun Xiao; Qingsong Wang; Jun Peng; Zhengtao Yu; Jikun Zhang; Ying Xia
Journal:  Mol Neurobiol       Date:  2022-10-08       Impact factor: 5.682

5.  Trans-cinnamaldehyde protected PC12 cells against oxygen and glucose deprivation/reperfusion (OGD/R)-induced injury via anti-apoptosis and anti-oxidative stress.

Authors:  Xue Qi; Ru Zhou; Yue Liu; Jing Wang; Wan-Nian Zhang; Huan-Ran Tan; Yang Niu; Tao Sun; Yu-Xiang Li; Jian-Qiang Yu
Journal:  Mol Cell Biochem       Date:  2016-08-16       Impact factor: 3.396

6.  Role of the tumour protein P53 gene in human cervical squamous carcinoma cells: Discussing haematopoietic cell-specific protein 1-associated protein X-1-induced survival, migration and proliferation.

Authors:  Bing Qian; Li-Jun Zhao; Fang Teng; Ling-Juan Gao; Rong Shen
Journal:  Oncol Lett       Date:  2018-06-04       Impact factor: 2.967

7.  In vivo [64Cu]CuCl2 PET imaging reveals activity of Dextran-Catechin on tumor copper homeostasis.

Authors:  Arvind Parmar; Giancarlo Pascali; Florida Voli; Luigi Lerra; Eugene Yee; Aria Ahmed-Cox; Kathleen Kimpton; Giuseppe Cirillo; Andrew Arthur; David Zahra; Gita Rahardjo; Guo Jun Liu; Nigel Lengkeek; Federica Saletta; Arnaud Charil; Maria Kavallaris; Orazio Vittorio
Journal:  Theranostics       Date:  2018-11-09       Impact factor: 11.556

8.  A Novel Drug Delivery Carrier Comprised of Nimodipine Drug Solution and a Nanoemulsion: Preparation, Characterization, in vitro, and in vivo Studies.

Authors:  Saixu Huang; Zhiyong Huang; Zhiqin Fu; Yamin Shi; Qi Dai; Shuyan Tang; Yongwei Gu; Youfa Xu; Jianming Chen; Xin Wu; Fuzheng Ren
Journal:  Int J Nanomedicine       Date:  2020-02-18

9.  NADPH is superior to NADH or edaravone in ameliorating metabolic disturbance and brain injury in ischemic stroke.

Authors:  Xin-Xin Wang; Fan Wang; Guang-Hui Mao; Jun-Chao Wu; Mei Li; Rong Han; Jing She; Rong Zhang; Rui Sheng; Zhong Chen; Zheng-Hong Qin
Journal:  Acta Pharmacol Sin       Date:  2021-06-24       Impact factor: 6.150

10.  Protective Effects of MitoTEMPO on Nonalcoholic Fatty Liver Disease via Regulating Myeloid-Derived Suppressor Cells and Inflammation in Mice.

Authors:  Jiayuan Wu; Li Zheng; Juanfen Mo; Xiujuan Yao; Chenliang Fan; Yi Bao
Journal:  Biomed Res Int       Date:  2020-07-30       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.